Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease.
Kaori TanabeKen-Ichi SamejimaFumihiro FukataTakaaki KosugiHideo TsushimaKatsuhiko MorimotoKeisuke OkamotoMasaru MatsuiMasahiro EriguchiNaoki MaruyamaYasuhiro AkaiKazuhiko TsuruyaPublished in: Clinical and experimental nephrology (2021)
The initial PSL dose was not associated with time to remission, remission rate, time to relapse, or relapse rate. Therefore, a low initial steroid dose may be sufficient to achieve remission.